Quantra and SEER Sonorheometry Performance for Traumatic Injury

Overview

About this study

The purpose of this study is to investigate if the Quantra point-of-care viscoelastic assay canprovide rapid assessment (within 15 minutes) of trauma-induced coagulopathy in the trauma resuscitation bay, as compared to standard laboratory assays (INR, Thromboelastography [TEG]), which take ≥ 60 minutes before final results become available.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Trauma activation level yellow or red.

Exclusion Criteria: 

  • Prisoners, greater than 12 hours from time of injury, current injuries related to suicide attempt.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/10/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Myung Park, M.D., M.S.

Open for enrollment

Contact information:

Nikoli Yudin EMT

(507) 255-7435

Yudin.Nikoli@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20551943

Mayo Clinic Footer